{"id":"W2581159256","doi":"10.1182/blood.v116.21.986.986","title":"Elotuzumab In Combination with Lenalidomide and Dexamethasone In Patients with Relapsed Multiple Myeloma: Interim Results of a Phase 2 Study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Dexamethasone; Medicine; Multiple myeloma; Regimen; Internal medicine; Adverse effect; Interim analysis; Premedication; Phases of clinical research; Nausea; Bortezomib; Oncology; Gastroenterology; Clinical trial; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00327553,0.00176113,0.003059663,0.0004066543,0.0004541114,0.001213425,0.001207666,0.001387822,0.001779567],"category_scores_gemma":[0.001155085,0.000688174,0.001964387,0.0005186341,0.00067597,0.001066188,0.0004291246,0.002631208,0.0007111432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001201488,"about_ca_system_score_gemma":0.001600647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007307283,"about_ca_topic_score_gemma":0.001432917,"domain_scores_codex":[0.9989505,0.0005432742,0.00007663346,0.0001697364,0.0001144134,0.0001453461],"domain_scores_gemma":[0.999108,0.0001481185,0.0001758593,0.00009064842,0.00006983749,0.0004075025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6907682,0.09437639,0.03003487,0.0008713555,0.004738264,0.0007724963,0.0004194456,0.002490465,0.02749258,0.0001668134,0.00316928,0.1446998],"study_design_scores_gemma":[0.5652873,0.3953913,0.03095961,0.00005921933,0.001312946,0.0005298271,0.00006117157,0.001211189,0.002194351,0.0001252674,0.002823085,0.00004467442],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991483,0.003680294,0.0004566235,0.0004754685,0.000102287,0.001943214,0.000782753,0.00007184952,0.001004491],"genre_scores_gemma":[0.9863949,0.00251801,0.002549651,0.001497464,0.0003181605,0.002411461,0.003048068,0.00003000277,0.001232217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00327553,"threshold_uncertainty_score":0.01732284,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0162487581708671,"score_gpt":0.2924617473551226,"score_spread":0.2762129891842556,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}